OTC Derivatives: Terrain Shifts to Favored Emerging Market Jurisdictions
|Feb 6th, 2012 | Filed under: Alpha Strategies, Today's Post | By: cfaille||
Celent has issued a report on the over-the-counter derivatives markets in Asia and Latin America. It contends that the central clearing of OTC derivatives will become a common feature of markets in those regions in the months and years to come, indeed, that a number of central counterparty clearinghouses will come on-line as early as later this year, and Celent senior analyst Anshuman Jaswal suspects this will change the geography of the markets.
The report begins with a comparison of the turnover across the global emerging and advanced markets. Asia represents roughly 70 percent of the turnover of the OTC derivatives market in the emerging markets nations, Latin America 20 percent. Jaswal says that economic growth in the emerging markets of the two regions under study is “ideally suited to the greater adoption of OTC derivatives.”
To continue reading this article please login (at the right) or click here to learn more about accessing our archives.
Christopher Faille is a Jamesian pragmatist. William James has taught him, for example, that "you can say of a line that it runs east, or you can say that it runs west, and the line per se accepts both descriptions without rebelling at the inconsistency."
- Future of Asia’s Synthetic ETF Market May Lie With Singapore Regulators
- Fine Print As Yet Unwritten, But the Gist is Clear for OTC Derivatives
- CSAM: The Emerging Market Nations Have Some ‘Bullets Left’
- Why is Singapore so hot?
- San Francisco Recap: Will “tectonic shifts” in the global economy finally give emerging markets hedge funds a chance to earn some alpha?